Translational Medicine
Open Access

David G Gorenstein

David Gorenstein, Ph.D., joined UTHealth January 1, 2009 as Professor and Deputy Director of the IMM. Dr. Gorenstein. He was most recently the Associate Dean for Research, School of Medicine, the University of Texas Medical Branch at Galveston (UTMB) and the Charles Marc Pomerat Distinguished Professor in the Departments of Biochemistry & Molecular Biology and Neurosciences & Cell Biology. He also served as the founding Director of the UTMB Sealy Center for Structural Biology and Director of the Gulf Coast Consortium in Magnetic Resonance, a shared facility that includes UTMB, Rice University, Baylor College of Medicine, the University of Houston, UTHealth and UT M.D. Anderson Cancer Center. He has nearly 40 years experience in structural biology, drug design, nucleic acid and protein chemistry with over 240 publications. He currently has major translational research programs in proteomics and nanomedicine for both diagnostics and therapeutics, particularly in cancer. He also has major programs in next-generation aptamer technologies and NMR structural biology, drug design, nucleic acid and protein chemistry. Dr. Gorenstein received a bachelors degree in chemistry from the Massachusetts Institute of Technology and a masters degree and doctorate in chemistry from Harvard University. Before moving to the Houston/Galveston area, he held faculty positions in the Departments of Chemistry at the University of Illinois at Chicago and Purdue University. He has received a number of awards, including Guggenheim (to the University of California San Francisco) and senior Fulbright (to Oxford University, England) fellowships and election as Fellow to the American Association for the Advancement of Science. Dr. Gorenstein holds over three dozen patents on novel aptamer technology (awarded and pending), many of which have been licensed to AptaMed and AM Biotechnologies, Galveston and Houston companies he founded.

Biochemistry, Neuroscience, Molecular Biology.